NervGen Pharma Corp is Shariah Compliant. It passes 3/5 Shariah standards we screen against.
NervGen Pharma Corp
(NGEN.V)
☆☆☆☆☆ 3/5
BBG00MMMWGD3
NGEN
Please log in to manage your watchlist.
NGEN
BBG00MMMWGD3
NGEN.V
- Updated on June 28, 2025
Financial Ratios
| AAOIFI | S&P | DJIM | FTSE | MSCI |
|---|---|---|---|---|
|
Debt: 0.02%
✓
Limit: 30% |
Debt: 0.05%
✓
Limit: 33% |
Debt: 0.05%
✓
Limit: 33% |
Debt: 0.52%
✓
Limit: 33.33% |
Debt: 0.52%
✓
Limit: 33.33% |
|
NCA: 0.02%
✓
Limit: 30% |
Cash: 91.88%
✗
Limit: 33.33% |
Cash: 91.88%
✗
Limit: 33.33% |
||
|
C+AR: 93.99%
✗
Limit: 50% |
C+AR: 93.99%
✗
Limit: 33.33% |
Impure Income ✓
N/A
-
Interest Income
1.75%
Total
1.75%
Purification & Zakat Calculator
Based on the AAOIFI standards
More Info
Purification & Zakat
- Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly).
- If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
- For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them.
Rulebook
- AAOIFI: Non-compliant liabilities (like Interest-based Debt) & Non-compliant Assets (like Interest-based Investments) should each be < 30% of Market cap. Source: AAOIFI SS21
- S&P Shariah: Interest-based Debt < 33% of 36-mo avg. Market cap. Source: S&P Shariah Methodology
- Dow Jones Islamic Market (DJIM) Rulebook: Interest-based Debt < 33% of 24-mo avg. Market cap. Source: DJIM Methodology
- FTSE Shariah: Interest-based Debt and Cash and interest-bearing items should each be < 33.33% of Total Assets. Accounts receivable and cash < 50% of Total Assets. Source: FTSE RUSSELL
- MSCI Islamic: Interest-based Debt, Cash and interest-bearing items, & Accounts receivable and cash should each be < 33.33% of Total Assets. Source: MSCI Islamic Indexes
- Impure income < 5% for all standards.
Spot an error or need clarification? Discuss it in the Community.
Is NGEN.V Stock Halal and Shariah Compliant?
Yes, NGEN.V (NervGen Pharma Corp) Stock is Shariah Compliant
Is NGEN – NervGen Pharma Corp Stock Halal to Invest in?
As of July 2025, NervGen Pharma Corp is Shariah Compliant. This is based on the last earnings report.
Sign up to see how many standards the stock passes. Get detailed Shariah screening report on Muslim Xchange. We screen based on five major Shariah standards (AAOIFI, S&P Shariah, Dow Jones Islamic, FTSE Shariah, and MSCI).
Do I need to purify my investment in NGEN – NervGen Pharma Corp
If the Company is Shariah Compliant and Halal to invest in, then you must purify if the company has any impure income and you hold the company for more than a financial period (e.g. quarter), according to AAOIFI standards.
How can I calculate purification and zakat for my shares in NGEN – NervGen Pharma Corp
You can use our Purification and Zakat calculator to calculate the amount you must pay for each of these requirements, provided the company is Compliant. You can also use upload or connect your Portfolio(s) to automatically calculate the Purification and Zakat for all your holdings.
You are Seeing a Limited View
Unlock Industry-grade Shariah Compliance for global stocks.
Trusted by Islamic funds managing $1B+
- Detailed Shariah Compliance Report for 5 standards
- Reliable screening by AAOIFI Certified Shariah Advisor & Auditor
- Purification & Zakat Calculator
- Link or Upload Portfolios
- Advanced Fundamental & Technical Research
- 10 years of financial statements
- Halal Stock Advisor
- ... and more!
